nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyclothiazide—CA1—stomach cancer	0.473	0.569	CbGaD
Methyclothiazide—CA2—stomach cancer	0.358	0.431	CbGaD
Methyclothiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA1—stomach cancer	0.00628	0.108	CbGpPWpGaD
Methyclothiazide—CA2—Erythrocytes take up carbon dioxide and release oxygen—CA1—stomach cancer	0.00602	0.104	CbGpPWpGaD
Methyclothiazide—CA4—Erythrocytes take up carbon dioxide and release oxygen—CA2—stomach cancer	0.00574	0.0988	CbGpPWpGaD
Methyclothiazide—CA1—Erythrocytes take up carbon dioxide and release oxygen—CA2—stomach cancer	0.00528	0.0908	CbGpPWpGaD
Methyclothiazide—CA4—Reversible hydration of carbon dioxide—CA1—stomach cancer	0.00499	0.0858	CbGpPWpGaD
Methyclothiazide—CA2—Reversible hydration of carbon dioxide—CA1—stomach cancer	0.00478	0.0823	CbGpPWpGaD
Methyclothiazide—CA4—Reversible hydration of carbon dioxide—CA2—stomach cancer	0.00456	0.0785	CbGpPWpGaD
Methyclothiazide—CA1—Reversible hydration of carbon dioxide—CA2—stomach cancer	0.00419	0.0721	CbGpPWpGaD
Methyclothiazide—SLC12A1—hematopoietic system—stomach cancer	0.00157	0.0926	CbGeAlD
Methyclothiazide—SLC12A1—epithelium—stomach cancer	0.00143	0.0846	CbGeAlD
Methyclothiazide—CA2—gall bladder—stomach cancer	0.00124	0.0729	CbGeAlD
Methyclothiazide—Muscle spasms—Floxuridine—stomach cancer	0.00112	0.013	CcSEcCtD
Methyclothiazide—CA1—hematopoietic system—stomach cancer	0.00108	0.0637	CbGeAlD
Methyclothiazide—Leukopenia—Floxuridine—stomach cancer	0.00105	0.0121	CcSEcCtD
Methyclothiazide—Respiratory distress—Capecitabine—stomach cancer	0.000959	0.0111	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Floxuridine—stomach cancer	0.000953	0.0111	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Floxuridine—stomach cancer	0.000933	0.0108	CcSEcCtD
Methyclothiazide—SLC12A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—stomach cancer	0.000922	0.0159	CbGpPWpGaD
Methyclothiazide—Anorexia—Floxuridine—stomach cancer	0.000909	0.0105	CcSEcCtD
Methyclothiazide—CA1—pancreas—stomach cancer	0.000878	0.0519	CbGeAlD
Methyclothiazide—Hypercalcaemia—Capecitabine—stomach cancer	0.000877	0.0102	CcSEcCtD
Methyclothiazide—Vision blurred—Mitomycin—stomach cancer	0.000864	0.01	CcSEcCtD
Methyclothiazide—SLC12A3—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC1A2—stomach cancer	0.000837	0.0144	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Floxuridine—stomach cancer	0.000829	0.00962	CcSEcCtD
Methyclothiazide—Leukopenia—Mitomycin—stomach cancer	0.00082	0.00952	CcSEcCtD
Methyclothiazide—CA1—lymphoid tissue—stomach cancer	0.000759	0.0448	CbGeAlD
Methyclothiazide—Body temperature increased—Floxuridine—stomach cancer	0.000754	0.00875	CcSEcCtD
Methyclothiazide—CA1—digestive system—stomach cancer	0.00075	0.0443	CbGeAlD
Methyclothiazide—Thrombocytopenia—Mitomycin—stomach cancer	0.000732	0.0085	CcSEcCtD
Methyclothiazide—Photosensitivity—Fluorouracil—stomach cancer	0.000721	0.00837	CcSEcCtD
Methyclothiazide—Anorexia—Mitomycin—stomach cancer	0.000713	0.00828	CcSEcCtD
Methyclothiazide—Hypersensitivity—Floxuridine—stomach cancer	0.000702	0.00815	CcSEcCtD
Methyclothiazide—CA2—hematopoietic system—stomach cancer	0.000699	0.0413	CbGeAlD
Methyclothiazide—CA1—bone marrow—stomach cancer	0.000692	0.0408	CbGeAlD
Methyclothiazide—Asthenia—Floxuridine—stomach cancer	0.000684	0.00794	CcSEcCtD
Methyclothiazide—Quinethazone—CA1—stomach cancer	0.000659	0.0822	CrCbGaD
Methyclothiazide—Diarrhoea—Floxuridine—stomach cancer	0.000652	0.00757	CcSEcCtD
Methyclothiazide—Decreased appetite—Mitomycin—stomach cancer	0.00065	0.00755	CcSEcCtD
Methyclothiazide—CA2—epithelium—stomach cancer	0.000639	0.0377	CbGeAlD
Methyclothiazide—CA1—endocrine gland—stomach cancer	0.00062	0.0366	CbGeAlD
Methyclothiazide—CA2—smooth muscle tissue—stomach cancer	0.000616	0.0364	CbGeAlD
Methyclothiazide—Cyclothiazide—CA1—stomach cancer	0.000612	0.0764	CrCbGaD
Methyclothiazide—Benzthiazide—CA1—stomach cancer	0.000612	0.0764	CrCbGaD
Methyclothiazide—Hypercalcaemia—Epirubicin—stomach cancer	0.000611	0.00709	CcSEcCtD
Methyclothiazide—Chlorothiazide—CA1—stomach cancer	0.000608	0.0759	CrCbGaD
Methyclothiazide—Diclofenamide—CA1—stomach cancer	0.000608	0.0759	CrCbGaD
Methyclothiazide—Vomiting—Floxuridine—stomach cancer	0.000606	0.00704	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Irinotecan—stomach cancer	0.000604	0.00701	CcSEcCtD
Methyclothiazide—Rash—Floxuridine—stomach cancer	0.000601	0.00698	CcSEcCtD
Methyclothiazide—Dermatitis—Floxuridine—stomach cancer	0.000601	0.00697	CcSEcCtD
Methyclothiazide—Headache—Floxuridine—stomach cancer	0.000597	0.00693	CcSEcCtD
Methyclothiazide—Cramp muscle—Irinotecan—stomach cancer	0.000595	0.00691	CcSEcCtD
Methyclothiazide—Body temperature increased—Mitomycin—stomach cancer	0.000591	0.00686	CcSEcCtD
Methyclothiazide—CA4—digestive system—stomach cancer	0.000586	0.0346	CbGeAlD
Methyclothiazide—CA2—pancreas—stomach cancer	0.000569	0.0336	CbGeAlD
Methyclothiazide—Nausea—Floxuridine—stomach cancer	0.000566	0.00657	CcSEcCtD
Methyclothiazide—Hypercalcaemia—Doxorubicin—stomach cancer	0.000565	0.00656	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Docetaxel—stomach cancer	0.00056	0.0065	CcSEcCtD
Methyclothiazide—Pancreatitis—Irinotecan—stomach cancer	0.00056	0.0065	CcSEcCtD
Methyclothiazide—CA1—liver—stomach cancer	0.000559	0.033	CbGeAlD
Methyclothiazide—CA4—bone marrow—stomach cancer	0.000541	0.0319	CbGeAlD
Methyclothiazide—Asthenia—Mitomycin—stomach cancer	0.000537	0.00623	CcSEcCtD
Methyclothiazide—Glycosuria—Epirubicin—stomach cancer	0.000524	0.00608	CcSEcCtD
Methyclothiazide—Hydroflumethiazide—CA1—stomach cancer	0.000513	0.0641	CrCbGaD
Methyclothiazide—Pneumonia—Irinotecan—stomach cancer	0.000512	0.00595	CcSEcCtD
Methyclothiazide—Diarrhoea—Mitomycin—stomach cancer	0.000512	0.00594	CcSEcCtD
Methyclothiazide—Photosensitivity—Capecitabine—stomach cancer	0.000504	0.00585	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Fluorouracil—stomach cancer	0.000499	0.0058	CcSEcCtD
Methyclothiazide—Quinethazone—CA2—stomach cancer	0.000499	0.0623	CrCbGaD
Methyclothiazide—Hydrochlorothiazide—CA1—stomach cancer	0.000499	0.0623	CrCbGaD
Methyclothiazide—Jaundice—Irinotecan—stomach cancer	0.000497	0.00576	CcSEcCtD
Methyclothiazide—Dizziness—Mitomycin—stomach cancer	0.000495	0.00574	CcSEcCtD
Methyclothiazide—Vascular purpura—Capecitabine—stomach cancer	0.000495	0.00574	CcSEcCtD
Methyclothiazide—CA2—lymphoid tissue—stomach cancer	0.000492	0.0291	CbGeAlD
Methyclothiazide—Pneumonia—Fluorouracil—stomach cancer	0.000491	0.0057	CcSEcCtD
Methyclothiazide—Haemolytic anaemia—Capecitabine—stomach cancer	0.00049	0.00569	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Methotrexate—stomach cancer	0.000489	0.00568	CcSEcCtD
Methyclothiazide—CA2—digestive system—stomach cancer	0.000486	0.0287	CbGeAlD
Methyclothiazide—Glycosuria—Doxorubicin—stomach cancer	0.000485	0.00563	CcSEcCtD
Methyclothiazide—CA4—endocrine gland—stomach cancer	0.000484	0.0286	CbGeAlD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000481	0.00827	CbGpPWpGaD
Methyclothiazide—Vomiting—Mitomycin—stomach cancer	0.000476	0.00552	CcSEcCtD
Methyclothiazide—Rash—Mitomycin—stomach cancer	0.000472	0.00548	CcSEcCtD
Methyclothiazide—Dermatitis—Mitomycin—stomach cancer	0.000471	0.00547	CcSEcCtD
Methyclothiazide—Headache—Mitomycin—stomach cancer	0.000469	0.00544	CcSEcCtD
Methyclothiazide—Vasculitis—Methotrexate—stomach cancer	0.000465	0.0054	CcSEcCtD
Methyclothiazide—Cyclothiazide—CA2—stomach cancer	0.000464	0.0579	CrCbGaD
Methyclothiazide—Benzthiazide—CA2—stomach cancer	0.000464	0.0579	CrCbGaD
Methyclothiazide—Blood uric acid increased—Methotrexate—stomach cancer	0.000462	0.00536	CcSEcCtD
Methyclothiazide—Chlorothiazide—CA2—stomach cancer	0.000461	0.0575	CrCbGaD
Methyclothiazide—Diclofenamide—CA2—stomach cancer	0.000461	0.0575	CrCbGaD
Methyclothiazide—Purpura—Capecitabine—stomach cancer	0.000459	0.00533	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Epirubicin—stomach cancer	0.000458	0.00531	CcSEcCtD
Methyclothiazide—Agranulocytosis—Fluorouracil—stomach cancer	0.000455	0.00529	CcSEcCtD
Methyclothiazide—CA2—bone marrow—stomach cancer	0.000448	0.0265	CbGeAlD
Methyclothiazide—Trichlormethiazide—CA1—stomach cancer	0.000445	0.0555	CrCbGaD
Methyclothiazide—Nausea—Mitomycin—stomach cancer	0.000444	0.00516	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—HSPA8—stomach cancer	0.000437	0.00753	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000437	0.00751	CbGpPWpGaD
Methyclothiazide—Blood uric acid increased—Epirubicin—stomach cancer	0.000432	0.00502	CcSEcCtD
Methyclothiazide—CA1—lymph node—stomach cancer	0.000428	0.0253	CbGeAlD
Methyclothiazide—Aplastic anaemia—Methotrexate—stomach cancer	0.000426	0.00494	CcSEcCtD
Methyclothiazide—Hyperuricaemia—Doxorubicin—stomach cancer	0.000423	0.00492	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Docetaxel—stomach cancer	0.000417	0.00484	CcSEcCtD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000412	0.00709	CbGpPWpGaD
Methyclothiazide—Cramp muscle—Docetaxel—stomach cancer	0.000411	0.00478	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Capecitabine—stomach cancer	0.000404	0.00469	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Methotrexate—stomach cancer	0.000404	0.00469	CcSEcCtD
Methyclothiazide—CA2—endocrine gland—stomach cancer	0.000402	0.0237	CbGeAlD
Methyclothiazide—Blood uric acid increased—Doxorubicin—stomach cancer	0.0004	0.00464	CcSEcCtD
Methyclothiazide—Aplastic anaemia—Epirubicin—stomach cancer	0.000399	0.00463	CcSEcCtD
Methyclothiazide—Hydroflumethiazide—CA2—stomach cancer	0.000389	0.0485	CrCbGaD
Methyclothiazide—Muscle spasms—Irinotecan—stomach cancer	0.000383	0.00444	CcSEcCtD
Methyclothiazide—Hydrochlorothiazide—CA2—stomach cancer	0.000378	0.0472	CrCbGaD
Methyclothiazide—Pulmonary oedema—Epirubicin—stomach cancer	0.000378	0.00439	CcSEcCtD
Methyclothiazide—Photosensitivity—Methotrexate—stomach cancer	0.000375	0.00435	CcSEcCtD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—SLC1A2—stomach cancer	0.000374	0.00643	CbGpPWpGaD
Methyclothiazide—Aplastic anaemia—Doxorubicin—stomach cancer	0.000369	0.00428	CcSEcCtD
Methyclothiazide—CA2—liver—stomach cancer	0.000362	0.0214	CbGeAlD
Methyclothiazide—Vision blurred—Fluorouracil—stomach cancer	0.000359	0.00417	CcSEcCtD
Methyclothiazide—Vertigo—Irinotecan—stomach cancer	0.000358	0.00415	CcSEcCtD
Methyclothiazide—Leukopenia—Irinotecan—stomach cancer	0.000356	0.00414	CcSEcCtD
Methyclothiazide—Pneumonia—Docetaxel—stomach cancer	0.000354	0.00411	CcSEcCtD
Methyclothiazide—Photosensitivity—Epirubicin—stomach cancer	0.000351	0.00407	CcSEcCtD
Methyclothiazide—Pulmonary oedema—Doxorubicin—stomach cancer	0.00035	0.00406	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000349	0.00405	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Capecitabine—stomach cancer	0.000349	0.00405	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Capecitabine—stomach cancer	0.000345	0.004	CcSEcCtD
Methyclothiazide—Vascular purpura—Epirubicin—stomach cancer	0.000345	0.004	CcSEcCtD
Methyclothiazide—Jaundice—Docetaxel—stomach cancer	0.000343	0.00398	CcSEcCtD
Methyclothiazide—Pneumonia—Capecitabine—stomach cancer	0.000343	0.00398	CcSEcCtD
Methyclothiazide—Leukopenia—Fluorouracil—stomach cancer	0.000341	0.00396	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000338	0.00392	CcSEcCtD
Methyclothiazide—Trichlormethiazide—CA2—stomach cancer	0.000337	0.0421	CrCbGaD
Methyclothiazide—CA4—lymph node—stomach cancer	0.000335	0.0198	CbGeAlD
Methyclothiazide—Jaundice—Capecitabine—stomach cancer	0.000332	0.00386	CcSEcCtD
Methyclothiazide—Agranulocytosis—Docetaxel—stomach cancer	0.000329	0.00381	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Irinotecan—stomach cancer	0.000325	0.00377	CcSEcCtD
Methyclothiazide—Photosensitivity—Doxorubicin—stomach cancer	0.000325	0.00377	CcSEcCtD
Methyclothiazide—Purpura—Epirubicin—stomach cancer	0.00032	0.00371	CcSEcCtD
Methyclothiazide—Vascular purpura—Doxorubicin—stomach cancer	0.000319	0.0037	CcSEcCtD
Methyclothiazide—Agranulocytosis—Capecitabine—stomach cancer	0.000318	0.00369	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Irinotecan—stomach cancer	0.000318	0.00369	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Fluorouracil—stomach cancer	0.000311	0.00361	CcSEcCtD
Methyclothiazide—Anorexia—Irinotecan—stomach cancer	0.00031	0.00359	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—GSTM1—stomach cancer	0.000308	0.00529	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Fluorouracil—stomach cancer	0.000305	0.00354	CcSEcCtD
Methyclothiazide—Erythema multiforme—Docetaxel—stomach cancer	0.000299	0.00347	CcSEcCtD
Methyclothiazide—Anorexia—Fluorouracil—stomach cancer	0.000297	0.00344	CcSEcCtD
Methyclothiazide—Purpura—Doxorubicin—stomach cancer	0.000296	0.00343	CcSEcCtD
Methyclothiazide—Paraesthesia—Irinotecan—stomach cancer	0.000292	0.00339	CcSEcCtD
Methyclothiazide—Erythema multiforme—Capecitabine—stomach cancer	0.000289	0.00336	CcSEcCtD
Methyclothiazide—Decreased appetite—Irinotecan—stomach cancer	0.000282	0.00328	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Epirubicin—stomach cancer	0.000281	0.00327	CcSEcCtD
Methyclothiazide—Paraesthesia—Fluorouracil—stomach cancer	0.000279	0.00324	CcSEcCtD
Methyclothiazide—Pancreatitis—Methotrexate—stomach cancer	0.000279	0.00324	CcSEcCtD
Methyclothiazide—Constipation—Irinotecan—stomach cancer	0.000278	0.00323	CcSEcCtD
Methyclothiazide—CA2—lymph node—stomach cancer	0.000278	0.0164	CbGeAlD
Methyclothiazide—Malnutrition—Docetaxel—stomach cancer	0.000275	0.00319	CcSEcCtD
Methyclothiazide—Decreased appetite—Fluorouracil—stomach cancer	0.00027	0.00314	CcSEcCtD
Methyclothiazide—Malnutrition—Capecitabine—stomach cancer	0.000266	0.00309	CcSEcCtD
Methyclothiazide—Muscle spasms—Docetaxel—stomach cancer	0.000265	0.00307	CcSEcCtD
Methyclothiazide—Pancreatitis—Epirubicin—stomach cancer	0.000261	0.00303	CcSEcCtD
Methyclothiazide—Orthostatic hypotension—Doxorubicin—stomach cancer	0.00026	0.00302	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Methotrexate—stomach cancer	0.00026	0.00302	CcSEcCtD
Methyclothiazide—Body temperature increased—Irinotecan—stomach cancer	0.000257	0.00298	CcSEcCtD
Methyclothiazide—Muscle spasms—Capecitabine—stomach cancer	0.000256	0.00297	CcSEcCtD
Methyclothiazide—Pneumonia—Methotrexate—stomach cancer	0.000255	0.00296	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000252	0.00292	CcSEcCtD
Methyclothiazide—Vision blurred—Capecitabine—stomach cancer	0.000251	0.00291	CcSEcCtD
Methyclothiazide—Urticaria—Fluorouracil—stomach cancer	0.000247	0.00287	CcSEcCtD
Methyclothiazide—Leukopenia—Docetaxel—stomach cancer	0.000246	0.00286	CcSEcCtD
Methyclothiazide—Body temperature increased—Fluorouracil—stomach cancer	0.000246	0.00286	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Epirubicin—stomach cancer	0.000243	0.00282	CcSEcCtD
Methyclothiazide—Pancreatitis—Doxorubicin—stomach cancer	0.000242	0.00281	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Epirubicin—stomach cancer	0.00024	0.00279	CcSEcCtD
Methyclothiazide—Vertigo—Capecitabine—stomach cancer	0.000239	0.00278	CcSEcCtD
Methyclothiazide—Hypersensitivity—Irinotecan—stomach cancer	0.000239	0.00278	CcSEcCtD
Methyclothiazide—Pneumonia—Epirubicin—stomach cancer	0.000239	0.00277	CcSEcCtD
Methyclothiazide—Leukopenia—Capecitabine—stomach cancer	0.000238	0.00277	CcSEcCtD
Methyclothiazide—Agranulocytosis—Methotrexate—stomach cancer	0.000237	0.00275	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000235	0.00273	CcSEcCtD
Methyclothiazide—Asthenia—Irinotecan—stomach cancer	0.000233	0.00271	CcSEcCtD
Methyclothiazide—Jaundice—Epirubicin—stomach cancer	0.000232	0.00269	CcSEcCtD
Methyclothiazide—Hypersensitivity—Fluorouracil—stomach cancer	0.000229	0.00266	CcSEcCtD
Methyclothiazide—Photosensitivity reaction—Doxorubicin—stomach cancer	0.000225	0.00261	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Docetaxel—stomach cancer	0.000225	0.00261	CcSEcCtD
Methyclothiazide—Hyperglycaemia—Doxorubicin—stomach cancer	0.000222	0.00258	CcSEcCtD
Methyclothiazide—Diarrhoea—Irinotecan—stomach cancer	0.000222	0.00258	CcSEcCtD
Methyclothiazide—Agranulocytosis—Epirubicin—stomach cancer	0.000222	0.00257	CcSEcCtD
Methyclothiazide—Pneumonia—Doxorubicin—stomach cancer	0.000221	0.00257	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Docetaxel—stomach cancer	0.00022	0.00255	CcSEcCtD
Methyclothiazide—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000218	0.00253	CcSEcCtD
Methyclothiazide—Erythema multiforme—Methotrexate—stomach cancer	0.000215	0.0025	CcSEcCtD
Methyclothiazide—Dizziness—Irinotecan—stomach cancer	0.000215	0.00249	CcSEcCtD
Methyclothiazide—Jaundice—Doxorubicin—stomach cancer	0.000214	0.00249	CcSEcCtD
Methyclothiazide—Anorexia—Docetaxel—stomach cancer	0.000214	0.00249	CcSEcCtD
Methyclothiazide—Diarrhoea—Fluorouracil—stomach cancer	0.000213	0.00247	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Capecitabine—stomach cancer	0.000213	0.00247	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.000209	0.0036	CbGpPWpGaD
Methyclothiazide—Anorexia—Capecitabine—stomach cancer	0.000207	0.00241	CcSEcCtD
Methyclothiazide—Vomiting—Irinotecan—stomach cancer	0.000207	0.0024	CcSEcCtD
Methyclothiazide—Dizziness—Fluorouracil—stomach cancer	0.000206	0.00239	CcSEcCtD
Methyclothiazide—Agranulocytosis—Doxorubicin—stomach cancer	0.000205	0.00238	CcSEcCtD
Methyclothiazide—Rash—Irinotecan—stomach cancer	0.000205	0.00238	CcSEcCtD
Methyclothiazide—Dermatitis—Irinotecan—stomach cancer	0.000205	0.00238	CcSEcCtD
Methyclothiazide—Headache—Irinotecan—stomach cancer	0.000204	0.00236	CcSEcCtD
Methyclothiazide—Paraesthesia—Docetaxel—stomach cancer	0.000202	0.00234	CcSEcCtD
Methyclothiazide—Erythema multiforme—Epirubicin—stomach cancer	0.000202	0.00234	CcSEcCtD
Methyclothiazide—Malnutrition—Methotrexate—stomach cancer	0.000198	0.0023	CcSEcCtD
Methyclothiazide—Vomiting—Fluorouracil—stomach cancer	0.000198	0.0023	CcSEcCtD
Methyclothiazide—Rash—Fluorouracil—stomach cancer	0.000196	0.00228	CcSEcCtD
Methyclothiazide—Dermatitis—Fluorouracil—stomach cancer	0.000196	0.00228	CcSEcCtD
Methyclothiazide—Paraesthesia—Capecitabine—stomach cancer	0.000195	0.00227	CcSEcCtD
Methyclothiazide—Decreased appetite—Docetaxel—stomach cancer	0.000195	0.00227	CcSEcCtD
Methyclothiazide—Headache—Fluorouracil—stomach cancer	0.000195	0.00226	CcSEcCtD
Methyclothiazide—Nausea—Irinotecan—stomach cancer	0.000193	0.00224	CcSEcCtD
Methyclothiazide—Constipation—Docetaxel—stomach cancer	0.000192	0.00223	CcSEcCtD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.00019	0.00327	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Capecitabine—stomach cancer	0.000189	0.00219	CcSEcCtD
Methyclothiazide—Vision blurred—Methotrexate—stomach cancer	0.000187	0.00217	CcSEcCtD
Methyclothiazide—Erythema multiforme—Doxorubicin—stomach cancer	0.000187	0.00217	CcSEcCtD
Methyclothiazide—Constipation—Capecitabine—stomach cancer	0.000186	0.00216	CcSEcCtD
Methyclothiazide—Malnutrition—Epirubicin—stomach cancer	0.000186	0.00215	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN2A—stomach cancer	0.000185	0.00319	CbGpPWpGaD
Methyclothiazide—Nausea—Fluorouracil—stomach cancer	0.000185	0.00215	CcSEcCtD
Methyclothiazide—Muscle spasms—Epirubicin—stomach cancer	0.000178	0.00207	CcSEcCtD
Methyclothiazide—Vertigo—Methotrexate—stomach cancer	0.000178	0.00207	CcSEcCtD
Methyclothiazide—Body temperature increased—Docetaxel—stomach cancer	0.000178	0.00206	CcSEcCtD
Methyclothiazide—Leukopenia—Methotrexate—stomach cancer	0.000178	0.00206	CcSEcCtD
Methyclothiazide—CA4—Metabolism—ACAD8—stomach cancer	0.000176	0.00304	CbGpPWpGaD
Methyclothiazide—Vision blurred—Epirubicin—stomach cancer	0.000175	0.00203	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—PTGS2—stomach cancer	0.000173	0.00298	CbGpPWpGaD
Methyclothiazide—Urticaria—Capecitabine—stomach cancer	0.000173	0.00201	CcSEcCtD
Methyclothiazide—Body temperature increased—Capecitabine—stomach cancer	0.000172	0.002	CcSEcCtD
Methyclothiazide—Malnutrition—Doxorubicin—stomach cancer	0.000172	0.00199	CcSEcCtD
Methyclothiazide—Agitation—Epirubicin—stomach cancer	0.000171	0.00198	CcSEcCtD
Methyclothiazide—CA2—Metabolism—ACAD8—stomach cancer	0.000169	0.00291	CbGpPWpGaD
Methyclothiazide—Vertigo—Epirubicin—stomach cancer	0.000167	0.00194	CcSEcCtD
Methyclothiazide—Leukopenia—Epirubicin—stomach cancer	0.000166	0.00193	CcSEcCtD
Methyclothiazide—Hypersensitivity—Docetaxel—stomach cancer	0.000165	0.00192	CcSEcCtD
Methyclothiazide—Muscle spasms—Doxorubicin—stomach cancer	0.000165	0.00192	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN1B—stomach cancer	0.000164	0.00283	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ACAD8—stomach cancer	0.000162	0.00279	CbGpPWpGaD
Methyclothiazide—Anaphylactic shock—Methotrexate—stomach cancer	0.000162	0.00188	CcSEcCtD
Methyclothiazide—Vision blurred—Doxorubicin—stomach cancer	0.000162	0.00188	CcSEcCtD
Methyclothiazide—Asthenia—Docetaxel—stomach cancer	0.000161	0.00187	CcSEcCtD
Methyclothiazide—Hypersensitivity—Capecitabine—stomach cancer	0.00016	0.00186	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Methotrexate—stomach cancer	0.000158	0.00184	CcSEcCtD
Methyclothiazide—Agitation—Doxorubicin—stomach cancer	0.000158	0.00183	CcSEcCtD
Methyclothiazide—CA4—Metabolism—GMPR2—stomach cancer	0.000157	0.00271	CbGpPWpGaD
Methyclothiazide—CA1—C-MYB transcription factor network—CCND1—stomach cancer	0.000157	0.0027	CbGpPWpGaD
Methyclothiazide—Asthenia—Capecitabine—stomach cancer	0.000156	0.00181	CcSEcCtD
Methyclothiazide—Vertigo—Doxorubicin—stomach cancer	0.000154	0.00179	CcSEcCtD
Methyclothiazide—Anorexia—Methotrexate—stomach cancer	0.000154	0.00179	CcSEcCtD
Methyclothiazide—Leukopenia—Doxorubicin—stomach cancer	0.000154	0.00178	CcSEcCtD
Methyclothiazide—Diarrhoea—Docetaxel—stomach cancer	0.000154	0.00178	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—CDKN1A—stomach cancer	0.000152	0.00261	CbGpPWpGaD
Methyclothiazide—Anaphylactic shock—Epirubicin—stomach cancer	0.000151	0.00176	CcSEcCtD
Methyclothiazide—CA2—Metabolism—GMPR2—stomach cancer	0.000151	0.00259	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Capecitabine—stomach cancer	0.000149	0.00173	CcSEcCtD
Methyclothiazide—Dizziness—Docetaxel—stomach cancer	0.000149	0.00172	CcSEcCtD
Methyclothiazide—Thrombocytopenia—Epirubicin—stomach cancer	0.000148	0.00172	CcSEcCtD
Methyclothiazide—Paraesthesia—Methotrexate—stomach cancer	0.000145	0.00169	CcSEcCtD
Methyclothiazide—CA1—Metabolism—GMPR2—stomach cancer	0.000145	0.00249	CbGpPWpGaD
Methyclothiazide—Anorexia—Epirubicin—stomach cancer	0.000144	0.00168	CcSEcCtD
Methyclothiazide—CA4—Metabolism—SUCLG1—stomach cancer	0.000144	0.00247	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—IDH3B—stomach cancer	0.000144	0.00247	CbGpPWpGaD
Methyclothiazide—Dizziness—Capecitabine—stomach cancer	0.000144	0.00167	CcSEcCtD
Methyclothiazide—Vomiting—Docetaxel—stomach cancer	0.000143	0.00166	CcSEcCtD
Methyclothiazide—Rash—Docetaxel—stomach cancer	0.000142	0.00164	CcSEcCtD
Methyclothiazide—Dermatitis—Docetaxel—stomach cancer	0.000141	0.00164	CcSEcCtD
Methyclothiazide—Decreased appetite—Methotrexate—stomach cancer	0.000141	0.00163	CcSEcCtD
Methyclothiazide—Headache—Docetaxel—stomach cancer	0.000141	0.00163	CcSEcCtD
Methyclothiazide—Anaphylactic shock—Doxorubicin—stomach cancer	0.00014	0.00163	CcSEcCtD
Methyclothiazide—Vomiting—Capecitabine—stomach cancer	0.000138	0.0016	CcSEcCtD
Methyclothiazide—CA2—Metabolism—SUCLG1—stomach cancer	0.000138	0.00237	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—IDH3B—stomach cancer	0.000138	0.00237	CbGpPWpGaD
Methyclothiazide—Thrombocytopenia—Doxorubicin—stomach cancer	0.000137	0.00159	CcSEcCtD
Methyclothiazide—Rash—Capecitabine—stomach cancer	0.000137	0.00159	CcSEcCtD
Methyclothiazide—Dermatitis—Capecitabine—stomach cancer	0.000137	0.00159	CcSEcCtD
Methyclothiazide—Headache—Capecitabine—stomach cancer	0.000136	0.00158	CcSEcCtD
Methyclothiazide—Paraesthesia—Epirubicin—stomach cancer	0.000136	0.00158	CcSEcCtD
Methyclothiazide—CA4—Metabolism—NDUFS1—stomach cancer	0.000134	0.0023	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NDUFV1—stomach cancer	0.000134	0.0023	CbGpPWpGaD
Methyclothiazide—Anorexia—Doxorubicin—stomach cancer	0.000134	0.00155	CcSEcCtD
Methyclothiazide—Nausea—Docetaxel—stomach cancer	0.000133	0.00155	CcSEcCtD
Methyclothiazide—CA1—Metabolism—SUCLG1—stomach cancer	0.000132	0.00227	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—IDH3B—stomach cancer	0.000132	0.00227	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Epirubicin—stomach cancer	0.000132	0.00153	CcSEcCtD
Methyclothiazide—Constipation—Epirubicin—stomach cancer	0.00013	0.0015	CcSEcCtD
Methyclothiazide—Nausea—Capecitabine—stomach cancer	0.000129	0.0015	CcSEcCtD
Methyclothiazide—Urticaria—Methotrexate—stomach cancer	0.000129	0.00149	CcSEcCtD
Methyclothiazide—CA2—Metabolism—NDUFS1—stomach cancer	0.000128	0.00221	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NDUFV1—stomach cancer	0.000128	0.00221	CbGpPWpGaD
Methyclothiazide—Body temperature increased—Methotrexate—stomach cancer	0.000128	0.00149	CcSEcCtD
Methyclothiazide—Paraesthesia—Doxorubicin—stomach cancer	0.000126	0.00146	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—MYC—stomach cancer	0.000126	0.00216	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NDUFV1—stomach cancer	0.000123	0.00211	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NDUFS1—stomach cancer	0.000123	0.00211	CbGpPWpGaD
Methyclothiazide—Decreased appetite—Doxorubicin—stomach cancer	0.000122	0.00141	CcSEcCtD
Methyclothiazide—Urticaria—Epirubicin—stomach cancer	0.00012	0.0014	CcSEcCtD
Methyclothiazide—Constipation—Doxorubicin—stomach cancer	0.00012	0.00139	CcSEcCtD
Methyclothiazide—Body temperature increased—Epirubicin—stomach cancer	0.00012	0.00139	CcSEcCtD
Methyclothiazide—Hypersensitivity—Methotrexate—stomach cancer	0.000119	0.00138	CcSEcCtD
Methyclothiazide—CA4—Metabolism—BLVRB—stomach cancer	0.000119	0.00205	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PGLS—stomach cancer	0.000119	0.00205	CbGpPWpGaD
Methyclothiazide—Asthenia—Methotrexate—stomach cancer	0.000116	0.00135	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—KRAS—stomach cancer	0.000116	0.002	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—BLVRB—stomach cancer	0.000114	0.00197	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PGLS—stomach cancer	0.000114	0.00197	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PPAP2A—stomach cancer	0.000114	0.00196	CbGpPWpGaD
Methyclothiazide—Hypersensitivity—Epirubicin—stomach cancer	0.000112	0.0013	CcSEcCtD
Methyclothiazide—SLC12A1—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000111	0.00192	CbGpPWpGaD
Methyclothiazide—Urticaria—Doxorubicin—stomach cancer	0.000111	0.00129	CcSEcCtD
Methyclothiazide—Body temperature increased—Doxorubicin—stomach cancer	0.000111	0.00129	CcSEcCtD
Methyclothiazide—Diarrhoea—Methotrexate—stomach cancer	0.000111	0.00129	CcSEcCtD
Methyclothiazide—CA1—Metabolism—BLVRB—stomach cancer	0.00011	0.00188	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PGLS—stomach cancer	0.00011	0.00188	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PPAP2A—stomach cancer	0.000109	0.00188	CbGpPWpGaD
Methyclothiazide—Asthenia—Epirubicin—stomach cancer	0.000109	0.00126	CcSEcCtD
Methyclothiazide—Dizziness—Methotrexate—stomach cancer	0.000107	0.00124	CcSEcCtD
Methyclothiazide—CA1—Metabolism—PPAP2A—stomach cancer	0.000104	0.0018	CbGpPWpGaD
Methyclothiazide—Diarrhoea—Epirubicin—stomach cancer	0.000104	0.0012	CcSEcCtD
Methyclothiazide—Hypersensitivity—Doxorubicin—stomach cancer	0.000103	0.0012	CcSEcCtD
Methyclothiazide—Vomiting—Methotrexate—stomach cancer	0.000103	0.00119	CcSEcCtD
Methyclothiazide—Rash—Methotrexate—stomach cancer	0.000102	0.00118	CcSEcCtD
Methyclothiazide—Dermatitis—Methotrexate—stomach cancer	0.000102	0.00118	CcSEcCtD
Methyclothiazide—Headache—Methotrexate—stomach cancer	0.000101	0.00118	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CKB—stomach cancer	0.000101	0.00174	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NDUFA2—stomach cancer	0.000101	0.00174	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—FBP1—stomach cancer	0.000101	0.00174	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CA1—stomach cancer	0.000101	0.00174	CbGpPWpGaD
Methyclothiazide—SLC12A3—SLC-mediated transmembrane transport—ALB—stomach cancer	0.000101	0.00174	CbGpPWpGaD
Methyclothiazide—Asthenia—Doxorubicin—stomach cancer	0.000101	0.00117	CcSEcCtD
Methyclothiazide—Dizziness—Epirubicin—stomach cancer	0.0001	0.00116	CcSEcCtD
Methyclothiazide—CA1—C-MYB transcription factor network—HRAS—stomach cancer	9.87e-05	0.0017	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CA1—stomach cancer	9.71e-05	0.00167	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NDUFA2—stomach cancer	9.71e-05	0.00167	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—FBP1—stomach cancer	9.71e-05	0.00167	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CKB—stomach cancer	9.71e-05	0.00167	CbGpPWpGaD
Methyclothiazide—Vomiting—Epirubicin—stomach cancer	9.63e-05	0.00112	CcSEcCtD
Methyclothiazide—Nausea—Methotrexate—stomach cancer	9.61e-05	0.00112	CcSEcCtD
Methyclothiazide—Diarrhoea—Doxorubicin—stomach cancer	9.59e-05	0.00111	CcSEcCtD
Methyclothiazide—Rash—Epirubicin—stomach cancer	9.55e-05	0.00111	CcSEcCtD
Methyclothiazide—Dermatitis—Epirubicin—stomach cancer	9.54e-05	0.00111	CcSEcCtD
Methyclothiazide—CA4—Metabolism—PLIN2—stomach cancer	9.53e-05	0.00164	CbGpPWpGaD
Methyclothiazide—Headache—Epirubicin—stomach cancer	9.49e-05	0.0011	CcSEcCtD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—HMOX1—stomach cancer	9.43e-05	0.00162	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CKB—stomach cancer	9.31e-05	0.0016	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NDUFA2—stomach cancer	9.31e-05	0.0016	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—FBP1—stomach cancer	9.31e-05	0.0016	CbGpPWpGaD
Methyclothiazide—Dizziness—Doxorubicin—stomach cancer	9.27e-05	0.00108	CcSEcCtD
Methyclothiazide—CA4—Metabolism—CA2—stomach cancer	9.27e-05	0.00159	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PLIN2—stomach cancer	9.13e-05	0.00157	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PGAM1—stomach cancer	9.03e-05	0.00155	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NT5E—stomach cancer	9.03e-05	0.00155	CbGpPWpGaD
Methyclothiazide—Nausea—Epirubicin—stomach cancer	9e-05	0.00104	CcSEcCtD
Methyclothiazide—Vomiting—Doxorubicin—stomach cancer	8.91e-05	0.00103	CcSEcCtD
Methyclothiazide—Rash—Doxorubicin—stomach cancer	8.84e-05	0.00103	CcSEcCtD
Methyclothiazide—Dermatitis—Doxorubicin—stomach cancer	8.83e-05	0.00102	CcSEcCtD
Methyclothiazide—Headache—Doxorubicin—stomach cancer	8.78e-05	0.00102	CcSEcCtD
Methyclothiazide—CA1—Metabolism—PLIN2—stomach cancer	8.76e-05	0.00151	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NT5E—stomach cancer	8.66e-05	0.00149	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PGAM1—stomach cancer	8.66e-05	0.00149	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDH7A1—stomach cancer	8.62e-05	0.00148	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PLCE1—stomach cancer	8.62e-05	0.00148	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—HMOX1—stomach cancer	8.57e-05	0.00147	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CA2—stomach cancer	8.52e-05	0.00147	CbGpPWpGaD
Methyclothiazide—Nausea—Doxorubicin—stomach cancer	8.33e-05	0.000966	CcSEcCtD
Methyclothiazide—CA1—Metabolism—NT5E—stomach cancer	8.3e-05	0.00143	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PGAM1—stomach cancer	8.3e-05	0.00143	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PLCE1—stomach cancer	8.26e-05	0.00142	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALDH7A1—stomach cancer	8.26e-05	0.00142	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—UMPS—stomach cancer	8.26e-05	0.00142	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—UMPS—stomach cancer	7.92e-05	0.00136	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDH7A1—stomach cancer	7.92e-05	0.00136	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PLCE1—stomach cancer	7.92e-05	0.00136	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ECHS1—stomach cancer	7.68e-05	0.00132	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PDHA1—stomach cancer	7.68e-05	0.00132	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—UMPS—stomach cancer	7.59e-05	0.00131	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PDHA1—stomach cancer	7.36e-05	0.00127	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ECHS1—stomach cancer	7.36e-05	0.00127	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TYMP—stomach cancer	7.22e-05	0.00124	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—FADS1—stomach cancer	7.22e-05	0.00124	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—APOA1—stomach cancer	7.15e-05	0.00123	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PDHA1—stomach cancer	7.06e-05	0.00121	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ECHS1—stomach cancer	7.06e-05	0.00121	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TYMP—stomach cancer	6.92e-05	0.00119	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—FADS1—stomach cancer	6.92e-05	0.00119	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—SREBF2—stomach cancer	6.76e-05	0.00116	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—RORA—stomach cancer	6.68e-05	0.00115	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TYMP—stomach cancer	6.64e-05	0.00114	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—FADS1—stomach cancer	6.64e-05	0.00114	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—APOA1—stomach cancer	6.49e-05	0.00112	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—SREBF2—stomach cancer	6.48e-05	0.00112	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—RORA—stomach cancer	6.41e-05	0.0011	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALDOB—stomach cancer	6.26e-05	0.00108	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—SREBF2—stomach cancer	6.21e-05	0.00107	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—RORA—stomach cancer	6.14e-05	0.00106	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALDOB—stomach cancer	6e-05	0.00103	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALOX5—stomach cancer	5.82e-05	0.001	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALDOB—stomach cancer	5.75e-05	0.00099	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—DPYD—stomach cancer	5.73e-05	0.000985	CbGpPWpGaD
Methyclothiazide—SLC12A1—Transmembrane transport of small molecules—ALB—stomach cancer	5.66e-05	0.000974	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALOX5—stomach cancer	5.58e-05	0.00096	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—DPYD—stomach cancer	5.49e-05	0.000944	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALOX5—stomach cancer	5.35e-05	0.00092	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—DPYD—stomach cancer	5.26e-05	0.000905	CbGpPWpGaD
Methyclothiazide—SLC12A3—Transmembrane transport of small molecules—ALB—stomach cancer	5.14e-05	0.000885	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTT1—stomach cancer	5.06e-05	0.000871	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CYP2A6—stomach cancer	5e-05	0.000861	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—AKR1C3—stomach cancer	4.87e-05	0.000838	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTT1—stomach cancer	4.85e-05	0.000835	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CYP2A6—stomach cancer	4.8e-05	0.000826	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ENO1—stomach cancer	4.74e-05	0.000816	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—AKR1C3—stomach cancer	4.67e-05	0.000803	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTT1—stomach cancer	4.65e-05	0.000801	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CYP2A6—stomach cancer	4.6e-05	0.000791	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ENO1—stomach cancer	4.55e-05	0.000783	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—AKR1C3—stomach cancer	4.47e-05	0.00077	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ENO1—stomach cancer	4.36e-05	0.00075	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CD44—stomach cancer	4.21e-05	0.000724	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CD44—stomach cancer	4.03e-05	0.000694	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CD44—stomach cancer	3.87e-05	0.000665	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PPP2R1A—stomach cancer	3.58e-05	0.000616	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTP1—stomach cancer	3.51e-05	0.000604	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—HMOX1—stomach cancer	3.46e-05	0.000595	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PPP2R1A—stomach cancer	3.43e-05	0.00059	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTP1—stomach cancer	3.36e-05	0.000579	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—HMOX1—stomach cancer	3.32e-05	0.000571	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PPP2R1A—stomach cancer	3.29e-05	0.000566	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—TYMS—stomach cancer	3.26e-05	0.000561	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTP1—stomach cancer	3.23e-05	0.000555	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—GSTM1—stomach cancer	3.22e-05	0.000555	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—HMOX1—stomach cancer	3.18e-05	0.000547	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—TYMS—stomach cancer	3.13e-05	0.000538	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—GSTM1—stomach cancer	3.09e-05	0.000532	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ERCC2—stomach cancer	3.03e-05	0.000522	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—TYMS—stomach cancer	3e-05	0.000516	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—GSTM1—stomach cancer	2.96e-05	0.00051	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ERCC2—stomach cancer	2.91e-05	0.0005	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—MTHFR—stomach cancer	2.85e-05	0.00049	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ERCC2—stomach cancer	2.79e-05	0.00048	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—MTHFR—stomach cancer	2.73e-05	0.00047	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—CAV1—stomach cancer	2.63e-05	0.000452	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—APOA1—stomach cancer	2.62e-05	0.000451	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—MTHFR—stomach cancer	2.62e-05	0.000451	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—CAV1—stomach cancer	2.52e-05	0.000434	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—APOA1—stomach cancer	2.51e-05	0.000433	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—CAV1—stomach cancer	2.42e-05	0.000416	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—APOA1—stomach cancer	2.41e-05	0.000415	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PPARG—stomach cancer	2.31e-05	0.000398	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PPARG—stomach cancer	2.22e-05	0.000381	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PPARG—stomach cancer	2.12e-05	0.000366	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—ALB—stomach cancer	2.08e-05	0.000358	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—ALB—stomach cancer	1.99e-05	0.000343	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—NOS3—stomach cancer	1.99e-05	0.000342	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—ALB—stomach cancer	1.91e-05	0.000329	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—NOS3—stomach cancer	1.91e-05	0.000328	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—NOS3—stomach cancer	1.83e-05	0.000314	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PTGS2—stomach cancer	1.82e-05	0.000313	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PTGS2—stomach cancer	1.74e-05	0.0003	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PTGS2—stomach cancer	1.67e-05	0.000288	CbGpPWpGaD
Methyclothiazide—CA4—Metabolism—PIK3CA—stomach cancer	1.12e-05	0.000192	CbGpPWpGaD
Methyclothiazide—CA2—Metabolism—PIK3CA—stomach cancer	1.07e-05	0.000185	CbGpPWpGaD
Methyclothiazide—CA1—Metabolism—PIK3CA—stomach cancer	1.03e-05	0.000177	CbGpPWpGaD
